Introduction Last year, I explored the Indian healthcare landscape for a Dutch medtech company that was evaluating market entry. Their solution focused on optimising warfarin dosages for thrombosis patients — a niche, high-impact segment. Although the company eventually shifted priorities and paused the India expansion, the research offered some powerful insights into the potential of India as a...
Bridging Borders in Thrombosis Care: A Dutch Innovation and the Indian Opportunity
B